vs
Side-by-side financial comparison of EVOLUTION PETROLEUM CORP (EPM) and TriSalus Life Sciences, Inc. (TLSI). Click either name above to swap in a different company.
EVOLUTION PETROLEUM CORP is the larger business by last-quarter revenue ($20.7M vs $13.2M, roughly 1.6× TriSalus Life Sciences, Inc.). EVOLUTION PETROLEUM CORP runs the higher net margin — 5.2% vs -73.9%, a 79.0% gap on every dollar of revenue. On growth, TriSalus Life Sciences, Inc. posted the faster year-over-year revenue change (59.8% vs 2.0%). Over the past eight quarters, TriSalus Life Sciences, Inc.'s revenue compounded faster (43.0% CAGR vs -5.2%).
TriSalus Life Sciences, Inc. is a clinical-stage biotechnology company focused on advancing immuno-oncology and interventional oncology solutions. It develops proprietary targeted drug delivery technologies designed to improve treatment efficacy for patients with liver, pancreatic and other hard-to-treat solid tumors, primarily operating in North American markets via partnerships with clinical care and research institutions.
EPM vs TLSI — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $20.7M | $13.2M |
| Net Profit | $1.1M | $-9.8M |
| Gross Margin | 44.3% | 86.7% |
| Operating Margin | 3.2% | -24.8% |
| Net Margin | 5.2% | -73.9% |
| Revenue YoY | 2.0% | 59.8% |
| Net Profit YoY | 158.4% | 3.5% |
| EPS (diluted) | $0.03 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $20.7M | $13.2M | ||
| Q3 25 | $21.3M | $11.6M | ||
| Q2 25 | $21.1M | $11.2M | ||
| Q1 25 | $22.6M | $9.2M | ||
| Q4 24 | $20.3M | $8.3M | ||
| Q3 24 | $21.9M | $7.3M | ||
| Q2 24 | $21.2M | $7.4M | ||
| Q1 24 | $23.0M | $6.5M |
| Q4 25 | $1.1M | $-9.8M | ||
| Q3 25 | $824.0K | $-10.8M | ||
| Q2 25 | $3.4M | $-8.3M | ||
| Q1 25 | $-2.2M | $-10.4M | ||
| Q4 24 | $-1.8M | $-10.1M | ||
| Q3 24 | $2.1M | $-2.4M | ||
| Q2 24 | $1.2M | $-4.3M | ||
| Q1 24 | $289.0K | $-13.2M |
| Q4 25 | 44.3% | 86.7% | ||
| Q3 25 | 38.5% | 83.5% | ||
| Q2 25 | 46.1% | 83.9% | ||
| Q1 25 | 40.7% | 83.7% | ||
| Q4 24 | 36.9% | 85.3% | ||
| Q3 24 | 46.2% | 86.3% | ||
| Q2 24 | 46.3% | 87.6% | ||
| Q1 24 | 45.2% | 85.0% |
| Q4 25 | 3.2% | -24.8% | ||
| Q3 25 | -0.4% | -77.9% | ||
| Q2 25 | 6.3% | -65.4% | ||
| Q1 25 | 7.0% | -79.9% | ||
| Q4 24 | -3.0% | -91.8% | ||
| Q3 24 | 8.5% | -118.9% | ||
| Q2 24 | 11.3% | -111.0% | ||
| Q1 24 | 9.1% | -180.8% |
| Q4 25 | 5.2% | -73.9% | ||
| Q3 25 | 3.9% | -93.5% | ||
| Q2 25 | 16.2% | -73.9% | ||
| Q1 25 | -9.7% | -113.2% | ||
| Q4 24 | -9.0% | -122.4% | ||
| Q3 24 | 9.4% | -32.6% | ||
| Q2 24 | 5.8% | -58.8% | ||
| Q1 24 | 1.3% | -204.5% |
| Q4 25 | $0.03 | $-0.22 | ||
| Q3 25 | $0.02 | $-0.96 | ||
| Q2 25 | $0.10 | $-0.27 | ||
| Q1 25 | $-0.07 | $-0.39 | ||
| Q4 24 | $-0.06 | $-0.38 | ||
| Q3 24 | $0.06 | $-0.12 | ||
| Q2 24 | $0.04 | $-0.21 | ||
| Q1 24 | $0.01 | $-0.60 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.8M | $20.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $67.5M | $-33.9M |
| Total Assets | $169.3M | $35.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.8M | $20.4M | ||
| Q3 25 | $714.0K | $22.7M | ||
| Q2 25 | $2.5M | $26.5M | ||
| Q1 25 | $5.6M | $13.0M | ||
| Q4 24 | $11.7M | $8.5M | ||
| Q3 24 | $6.9M | $11.3M | ||
| Q2 24 | $6.4M | $16.5M | ||
| Q1 24 | $3.1M | $4.0M |
| Q4 25 | $67.5M | $-33.9M | ||
| Q3 25 | $69.1M | $-26.7M | ||
| Q2 25 | $71.8M | $-19.4M | ||
| Q1 25 | $71.7M | $-34.4M | ||
| Q4 24 | $76.3M | $-25.9M | ||
| Q3 24 | $79.6M | $-20.4M | ||
| Q2 24 | $81.1M | $-25.3M | ||
| Q1 24 | $83.5M | $-36.0M |
| Q4 25 | $169.3M | $35.3M | ||
| Q3 25 | $169.1M | $36.5M | ||
| Q2 25 | $160.3M | $41.3M | ||
| Q1 25 | $156.4M | $28.6M | ||
| Q4 24 | $160.2M | $24.0M | ||
| Q3 24 | $157.9M | $27.5M | ||
| Q2 24 | $162.9M | $32.4M | ||
| Q1 24 | $166.5M | $17.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $5.4M | $-2.5M |
| Free Cash FlowOCF − Capex | — | $-2.5M |
| FCF MarginFCF / Revenue | — | -19.1% |
| Capex IntensityCapex / Revenue | — | 0.3% |
| Cash ConversionOCF / Net Profit | 5.09× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-19.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.4M | $-2.5M | ||
| Q3 25 | $7.8M | $-3.7M | ||
| Q2 25 | $10.5M | $-7.3M | ||
| Q1 25 | $7.3M | $-4.5M | ||
| Q4 24 | $7.7M | $-5.7M | ||
| Q3 24 | $7.6M | $-10.8M | ||
| Q2 24 | $8.0M | $-13.4M | ||
| Q1 24 | $3.4M | $-10.9M |
| Q4 25 | — | $-2.5M | ||
| Q3 25 | — | $-3.9M | ||
| Q2 25 | — | $-7.4M | ||
| Q1 25 | — | $-5.3M | ||
| Q4 24 | — | $-5.8M | ||
| Q3 24 | — | $-11.0M | ||
| Q2 24 | — | $-13.5M | ||
| Q1 24 | — | $-10.9M |
| Q4 25 | — | -19.1% | ||
| Q3 25 | — | -33.9% | ||
| Q2 25 | — | -66.1% | ||
| Q1 25 | — | -57.3% | ||
| Q4 24 | — | -69.7% | ||
| Q3 24 | — | -149.9% | ||
| Q2 24 | — | -183.1% | ||
| Q1 24 | — | -169.3% |
| Q4 25 | — | 0.3% | ||
| Q3 25 | — | 1.9% | ||
| Q2 25 | — | 0.8% | ||
| Q1 25 | — | 8.2% | ||
| Q4 24 | — | 0.6% | ||
| Q3 24 | — | 2.3% | ||
| Q2 24 | — | 0.8% | ||
| Q1 24 | — | 1.0% |
| Q4 25 | 5.09× | — | ||
| Q3 25 | 9.47× | — | ||
| Q2 25 | 3.06× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.69× | — | ||
| Q2 24 | 6.47× | — | ||
| Q1 24 | 11.64× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EPM
| Crude Oil | $10.7M | 52% |
| Natural Gas Reserves | $7.4M | 36% |
| Natural Gas Liquids Reserves | $2.5M | 12% |
TLSI
Segment breakdown not available.
